Drug Type Small molecule drug |
Synonyms LNK 01009, LNK01009 |
Target |
Action modulators |
Mechanism TYK2 modulators(Tyrosine-protein kinase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | China | 01 Dec 2024 | |
Lupus Erythematosus | Preclinical | China | 01 Dec 2024 |